Related Experiment Video
Updated: Jan 11, 2026

Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
Handling Multi-Source Uncertainty in Accelerated Degradation Through a Wiener-Based Robust Modeling Scheme
Hua Tu1, Xiuli Wang2,3, Yang Li1
1School of Mechatronic Engineering and Automation, Shanghai University, Shanghai 200444, China.
None:
Uncertainty from heterogeneous degradation paths, limited experimental samples, and exogenous perturbations often complicates accelerated lifetime modeling and prediction. To confront these intertwined challenges, a Wiener process-based robust framework is developed. The proposed approach incorporates random-effect structures to capture unit-to-unit variability, adopts interval-based inference to reflect sampling limitations, and employs a hybrid estimator, combining Huber-type loss with a Metropolis-Hastings algorithm, to suppress the influence of external disturbances. In addition, a quantitative stress-parameter linkage is established under the accelerated factor principle, supporting consistent transfer from accelerated testing to normal conditions. Validation on contact stress relaxation data of connectors confirms that this methodology achieves more stable parameter inference and improves the reliability of lifetime predictions.
Related Concept Videos
Propagation of Uncertainty from Systematic Error
Propagation of Uncertainty from Random Error
Uncertainty: Overview
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Uncertainty: Confidence Intervals
Parameters Affecting Nonlinear Elimination: Zero-Order Input, First-Order Absorption and Two-Compartment Model
When a drug is administered through a constant intravenous infusion and eliminated via nonlinear pharmacokinetics, it follows zero-order input. For example, oral drugs undergo first-order absorption upon administration and are eliminated through nonlinear pharmacokinetics.
In the case of subcutaneously administered drugs,...

